Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has entered into an evaluation and option agreement with ADC Therapeutics SA. Biocytogen will grant ADC...
Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure...
Alcami, a leading contract development and manufacturing organization (CDMO), announced the completion of Phase II of its cGMP biostorage facility located in Amherst, New...
